Zhongxing Jiang
- Hematology top 2%
- Acute Myeloid Leukemia Research 28
- Hematopoietic Stem Cell Transplantation 11
- Multiple Myeloma Research and Treatments 8
- Chronic Myeloid Leukemia Treatments 7
- Immunology top 5%
- Immunotherapy and Immune Responses 8
- Immune Cell Function and Interaction 7
- Oncology top 5%
- CAR-T cell therapy research 7
- Cancer Research top 10%
- Genetics top 10%
-
- Acute Lymphoblastic Leukemia research 11
- Cited by
- HematologyImmunologyOncology
- Journals
- Blood (6 papers)Scientific Reports (5 papers)Experimental Hematology and Oncology (5 papers)
- Partner nations
- ChinaUnited StatesAustria
In The Last Decade
Zhongxing Jiang
73 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Hematology 392
- Immunology 573
- Oncology 503
- Cancer Research 237
- Genetics 110
Countries citing papers authored by Zhongxing Jiang
This map shows the geographic impact of Zhongxing Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongxing Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongxing Jiang more than expected).
Fields of papers citing papers by Zhongxing Jiang
This network shows the impact of papers produced by Zhongxing Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongxing Jiang. The network helps show where Zhongxing Jiang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhongxing Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 33 | |
| 4 | 2024 | 12 | |
| 5 | 2023 | 37 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 5 | |
| 11 | 2022 | 6 | |
| 12 | 2021 | 14 | |
| 13 | 2021 | 71 | |
| 14 | 2020 | 6 | |
| 15 | 2020 | 7 | |
| 16 | 2019 | 6 | |
| 17 | 2019 | 32 | |
| 18 | 2019 | 0 | |
| 19 | 2019 | 0 | |
| 20 | 2017 | 0 |
About Zhongxing Jiang
Zhongxing Jiang is a scholar working on Hematology, Immunology and Oncology, having authored 79 papers that have together received 1.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (28 papers), Hematopoietic Stem Cell Transplantation (11 papers), Acute Lymphoblastic Leukemia research (11 papers), Multiple Myeloma Research and Treatments (8 papers), Immunotherapy and Immune Responses (8 papers), CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (7 papers) and Chronic Myeloid Leukemia Treatments (7 papers). The work is most often cited by research in Hematology (392 citations), Immunology (573 citations) and Oncology (503 citations). Zhongxing Jiang has collaborated with scholars based in China, United States and Austria. Frequent co-authors include Jifeng Yu, Yongping Song, Haowei Sun, Wenzhi Tian, Weijie Cao, Yingmei Li, Haizhou Xing, Dingming Wan, Xinsheng Xie and Rong Guo. Their work appears in journals such as Blood, Scientific Reports, Experimental Hematology and Oncology, Biomarker Research and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.